Xing Y, et al. - Using a nationwide registry (Improving Care for Cardiovascular Disease in China project), researchers evaluated the use of pre-hospital statins and low-density lipoprotein cholesterol (LDL-C) levels at admission in 6,523 patients with acute coronary syndrome (ACS) and a history of myocardial infarction (MI) or revascularization. Initial admission lipid testing was performed to determine LDL-C levels. Among the overall study population, half were not being treated with statin therapy before admission, and LDL-C < 70 mg/dL were not attained by the majority; however, pre-hospital statin use was reported. The authors suggested that there may exist an opportunity to provide intensive statin or combination lipid-lowering therapy to this very-high risk patient population.